UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Transfer Factor as an Option for Managing the COVID-19 Pandemic

Folia biologica, 2020-01, Vol.66 (3), p.86-90

2020

Volltextzugriff (PDF)

Transfer factor: an overlooked potential for the prevention and treatment of infectious diseases

Folia biologica, 2013-01, Vol.59 (2), p.53-67

2013

Volltextzugriff (PDF)

Immunotherapeutic approaches for renal cancer

Folia biologica, 2002, Vol.48 (5), p.167-181

2002

Volltextzugriff (PDF)

Allogeneic gene-modified tumour cells in metastatic kidney cancer. Report II

Folia biologica, 2004, Vol.50 (6), p.175-183

2004

Volltextzugriff (PDF)

Allogeneic gene-modified tumour cells in metastatic kidney cancer. Preliminary report

Folia biologica, 2003, Vol.49 (4), p.147-159

2003

Volltextzugriff (PDF)

Immunotherapy of metastatic kidney cancer

International journal of cancer, 2001-10, Vol.94 (1), p.109-120

2001

Volltextzugriff (PDF)

Specific transfer factor with activity against Epstein-Barr virus reduces late relapse in endemic Burkitt's lymphoma

Anticancer research, 1990-09, Vol.10 (5A), p.1183

1990

Volltextzugriff (PDF)

In vitro production of human antibodies against bladder cancer: characterization and diagnostic implications

Journal of experimental pathology, 1987, Vol.3 (4), p.335

1987

Volltextzugriff (PDF)

Transfer Factor for the Treatment of HBsAg-Positive Chronic Active Hepatitis

Experimental biology and medicine (Maywood, N.J.), 1985-03, Vol.178 (3), p.468-475

1985

Volltextzugriff (PDF)

Transfer factor in malignancy

Progress in drug research, 1994, Vol.42, p.401

1994

Volltextzugriff (PDF)

Intratumoral echo-guided injection of interleukin-2 and lymphokine-activated killer cells in hepatocellular carcinoma

Hepato-gastroenterology, 1989-10, Vol.36 (5), p.352

1989

Volltextzugriff (PDF)

Transfer factor adjuvant therapy in nonsmall-cell lung carcinoma. (NSCLC) after surgery and radiotherapy

Journal of experimental pathology, 1987, Vol.3 (4), p.565

1987

Volltextzugriff (PDF)

Interleukin-2 in the treatment of infiltrating bladder cancer

Journal of experimental pathology, 1987, Vol.3 (4), p.525

1987

Volltextzugriff (PDF)

EBV associated malignancies

Journal of experimental pathology, 1987, Vol.3 (4), p.449

1987

Volltextzugriff (PDF)

Interleukin-2 treatment of lung metastases of a mammary adenocarcinoma. A case report

Journal of experimental pathology, 1987, Vol.3 (4), p.533

1987

Volltextzugriff (PDF)

Immune ribonucleic acid (I-RNA) in the treatment of metastatic renal cell carcinoma

Journal of experimental pathology, 1987, Vol.3 (4), p.515

1987

Volltextzugriff (PDF)

Tumour regression after intralesional injection of interleukin 2 (IL‐2) in bladder cancer. Preliminary report

International journal of cancer, 1984-01, Vol.34 (3), p.359-367

1984

Volltextzugriff (PDF)

An approach of combined loco-regional adoptive immunotherapy and subcutaneous vaccination by allogeneic-IL2 gene-transfected tumor cell lines admixed with autologous tumor cells in patients with relapsed glioblastoma

Clinical neurology and neurosurgery, 1997-07, Vol.99, p.S4-S4

1997

Volltextzugriff (PDF)

Treatment of chronic B virus hepatitis with specific transfer factor

Journal of experimental pathology, 1987, Vol.3 (4), p.421

1987

Volltextzugriff (PDF)

Transfer factor in prevention of Burkitt's lymphoma relapses

Journal of experimental pathology, 1987, Vol.3 (4), p.463

1987

Volltextzugriff (PDF)

In vitro produced human antibodies in the treatment of superficial bladder cancer

Journal of experimental pathology, 1987, Vol.3 (4), p.347

1987

Volltextzugriff (PDF)

Allogeneic Gene-Modified Tumour Cells in Metastatic Kidnev Cancer. Preliminary Report

Folia biologica, 2003-01, Vol.49 (4), p.147-159

2003

Volltextzugriff (PDF)

Transfer factor in chronic mucocutaneous candidiasis

Biotherapy (Dordrecht), 1996-01, Vol.9 (1-3), p.97-103

1996

Volltextzugriff (PDF)

Transfer factor as an adjuvant to non-small cell lung cancer (NSCLC) therapy

Biotherapy (Dordrecht), 1996-01, Vol.9 (1-3), p.117-121

1996

Volltextzugriff (PDF)

Efficacy of transfer factor in treating patients with recurrent ocular herpes infections

Biotherapy (Dordrecht), 1996-01, Vol.9 (1-3), p.61-66

1996

Volltextzugriff (PDF)

1 – 25 von 183

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(144)
Mit Volltextzugriff
(131)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Transfer Factor as an Option for Managing the COVID-19 Pandemic

Transfer factor: an overlooked potential for the prevention and treatment of infectious diseases

Immunotherapeutic approaches for renal cancer

Allogeneic gene-modified tumour cells in metastatic kidney cancer. Report II

Allogeneic gene-modified tumour cells in metastatic kidney cancer. Preliminary report

Immunotherapy of metastatic kidney cancer

Specific transfer factor with activity against Epstein-Barr virus reduces late relapse in endemic Burkitt's lymphoma

In vitro production of human antibodies against bladder cancer: characterization and diagnostic implications

Transfer Factor for the Treatment of HBsAg-Positive Chronic Active Hepatitis

Transfer factor in malignancy

Intratumoral echo-guided injection of interleukin-2 and lymphokine-activated killer cells in hepatocellular carcinoma

Transfer factor adjuvant therapy in nonsmall-cell lung carcinoma. (NSCLC) after surgery and radiotherapy

Interleukin-2 in the treatment of infiltrating bladder cancer

EBV associated malignancies

Interleukin-2 treatment of lung metastases of a mammary adenocarcinoma. A case report

Immune ribonucleic acid (I-RNA) in the treatment of metastatic renal cell carcinoma

Tumour regression after intralesional injection of interleukin 2 (IL‐2) in bladder cancer. Preliminary report

An approach of combined loco-regional adoptive immunotherapy and subcutaneous vaccination by allogeneic-IL2 gene-transfected tumor cell lines admixed with autologous tumor cells in patients with relapsed glioblastoma

Treatment of chronic B virus hepatitis with specific transfer factor

Transfer factor in prevention of Burkitt's lymphoma relapses

In vitro produced human antibodies in the treatment of superficial bladder cancer

Allogeneic Gene-Modified Tumour Cells in Metastatic Kidnev Cancer. Preliminary Report

Transfer factor in chronic mucocutaneous candidiasis

Transfer factor as an adjuvant to non-small cell lung cancer (NSCLC) therapy

Efficacy of transfer factor in treating patients with recurrent ocular herpes infections

Suchergebnisse filtern